Stella Diagnostics (Stella Diagnostics) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Stella Diagnostics's net issuance of preferred for the three months ended in Sep. 2023 was $0.00 Mil. The number is 0, which means that Stella Diagnostics has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Stella Diagnostics's net issuance of preferred for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Stella Diagnostics Net Issuance of Preferred Stock Historical Data

The historical data trend for Stella Diagnostics's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Net Issuance of Preferred Stock Chart

Stella Diagnostics Annual Data

Trend

Net Issuance of Preferred Stock

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Net Issuance of Preferred Stock	-	-

Stella Diagnostics Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Stella Diagnostics Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.